• 1
    Margarit C, Rimola A, Gonzalez-Pinto I, Cuervas-Mons V, Edo A, Andreu H, et al. Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation. Transpl Int 1998; 11( Suppl 1): S260266.
  • 2
    International Working Party. Terminology for hepatic allograft rejection. Hepatology 1995; 22: 648654.
  • 3
    Anonymous. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658663.
  • 4
    Update of the International Banff Schema for Liver allograft Rejection: Working recommendations for histopathological staging and reporting of chronic rejection. Hepatology 2000; 31: 792799.
  • 5
    Demetris A, Rupert K, Dvorchik I, Jain A, Minvervini M, Nalesnik MA, et al. Realtime monitoring of acute liver-allograft rejection using the Banff schema. Transplantation 2002; 9: 12901296.
  • 6
    Ormonde DG, de Boer WB, Kierath A, Bell R, Shilkin KB, House AK, et al. Banff schema for grading liver allograft rejection: utility in clinical practice. Liver Transpl Surg 1999; 5: 261267.
  • 7
    Blakolmer K, Jain A, Ruppert K, Gray E, Duquesnoy R, Murase N, et al. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. Transplantation 2000; 69: 23302336.
  • 8
    Neuberger J, Adams D. What is the significance of acute liver allograft rejection? J Hepatology 1998; 29: 143150.
  • 9
    Dousset B, Conti F, Cherruau B, Louvel A, Soubrane O, Houssin D, Calmus Y. Is acute rejection deleterious to long-term liver allograft function? J Hepatology 1998; 29: 660668.
  • 10
    Bartlett AS, Ramadas R, Furness S, Gane E, McCall JL. The natural history of acute histologic rejection without biochemical graft dysfunction in orthotopic liver transplantation: a systematic review. Liver Transpl 2002; 8: 11471153.
  • 11
    Farges O, Nocci KA, Sebagh M, Reynes M, Bismuth H. Low incidence of chronic rejection in patients experiencing histological acute rejection without simultaneous impairment in liver function tests. Transplant Proc 1995; 27: 11421143.
  • 12
    Gouv ASH, van den Heuvel MC, van den Berg AP, Sloff MJH, deJong KP, Poppema S. Significance of parenchemymal changes of acute cellular rejection in predicting chronic liver graft rejection. Transplantation 2002: 73: 243247.
  • 13
    Candinas D, Gunson BK, Nightingale P, Hubscher S, McMaster P, Neuberger JM. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 1995; 346: 11171121.
  • 14
    Paloma JC, Jiminez C, Moreno E, Garcia MA, Brewed J, Loinaz C, et al. Effects of intraoperative blood transfusion on rejection and survival after Orthotopic liver transplantation. Transplant Proceeding 1995; 27: 23262327.
  • 15
    Neil DA, Hübscher SG. Histologic and biochemical changes during the evolution of chronic rejection of liver allografts. Hepatology 2002; 35: 639651.
  • 16
    Lovell MO, Speeg KV, Halff GA, Molina DK, Sharkey FE. Acute hepatic allograft rejection: a comparison of patients with and without centrilobular alterations during first rejection episode. Liver Transpl 2004; 10: 369373.
  • 17
    Hassoun Z, Shah V, Lohse CM, Pankratz VS, Petrovic LM. Centrilobular necrosis after orthotopic liver transplantation: Association with acute cellular rejection and Impact on Outcome. Liver Transpl 2004; 10: 480487.
  • 18
    Calne R. WOFIE hypothesis: some thoughts on an approach toward allograft tolerance. Transplant Proc 1996; 28: 1152.
  • 19
    Dresske B, Zavazava N, Huang DS, Lin X, Kremer B, Fandrich F. WOFIE augments the immunosuppressive potency of FK-506. Window of opportunity for immunological engagement. Transpl Immunol 1998; 6: 243249.
  • 20
    Tippner C, Nashan B, Hoshino K, Schmidt-Sandte E, Akimaru K, Boker KH, et al. Clinical and subclinical acute rejection early after liver transplantation: contributing factors and relevance for the long-term course. Transplantation 2001; 72: 11221128.